Company Overview of CellMed AG
CellMed AG operates as a biotech company. The company focuses on its own therapeutic drug development. It develops bead product for cosmetic dermatology; and drug-eluting bead product for the treatment of stroke, based on proprietary stem cell. CellMed AG offers CellBeads, micro-implants, which produce proteins in the human body; and contain living cells that deliver therapeutic molecules to treat certain diseases. The company was founded in 2000, and is based in Alzenau, Germany. As of March 7, 2005, CellMed AG is a subsidiary of Biocompatibles International plc.
Founded in 2000
49 6023 9181 0
49 6023 9181 33
Key Executives for CellMed AG
Similar Private Companies By Industry
|HUMAN Gesellschaft für Biochemica und Diagnostica mbH||Europe|
|Santhera Pharmaceuticals (Deutschland) GmbH||Europe|
|ImClone Systems International GmbH||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact CellMed AG, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.